Zobowiązania Handlowe Zmiana Data
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Bayer EUR 6.59B 496M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
CSL USD 3.17B 290M 2025-12
Curis USD 5.61M 1.52M 2025-12
Eli Lilly USD 5.03B 350M 2026-03
Exelixis USD 24.15M 5.47M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
Merck USD 3.86B 541M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Takeda JPY 491.34B 23.75B 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03
Verastem USD 12.45M 2.56M 2025-12
Xoma USD 2.65M 1.52M 2025-09